Covalent capture of a human O6-alkylguanine alkyltransferase–DNA complex using N1,O6-ethanoxanthosine, a mechanism-based crosslinker
AUTOR(ES)
Noll, David M.
FONTE
Oxford University Press
RESUMO
The DNA repair protein O6-alkylguanine alkyltransferase (AGT) is responsible for removing promutagenic alkyl lesions from exocyclic oxygens located in the major groove of DNA, i.e. the O6 and O4 positions of guanine and thymine. The protein carries out this repair reaction by transferring the alkyl group to an active site cysteine and in doing so directly repairs the premutagenic lesion in a reaction that inactivates the protein. In order to trap a covalent AGT–DNA complex, oligodeoxyribonucleotides containing the novel nucleoside N1,O6-ethanoxanthosine (eX) have been prepared. The eX nucleoside was prepared by deamination of 3′,5′-protected O6-hydroxyethyl-2′-deoxyguanosine followed by cyclization to produce 3′,5′-protected N1,O6-ethano-2′-deoxyxanthosine, which was converted to the nucleoside phosphoramidite and used in the preparation of oligodeoxyribonucleotides. Incubation of human AGT with a DNA duplex containing eX resulted in the formation of a covalent protein–DNA complex. Formation of this complex was dependent on both active human AGT and eX and could be prevented by chemical inactivation of the AGT with O6-benzylguanine. The crosslinking of AGT to DNA using eX occurs with high yield and the resulting complex appears to be well suited for further biochemical and biophysical characterization.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=60232Documentos Relacionados
- DNA-binding mechanism of the Escherichia coli Ada O6-alkylguanine–DNA alkyltransferase
- Crystal structure of the human O6-alkylguanine-DNA alkyltransferase
- Formation of covalent complexes between human O6-alkylguanine-DNA alkyltransferase and BCNU-treated defined length synthetic oligodeoxynucleotides.
- O6 alkylguanine-DNA alkyltransferase activity in human myeloid cells.
- Evidence that covalent complex formation between BCNU-treated oligonucleotides and E. coli alkyltransferases requires the O6-alkylguanine function.
